» Articles » PMID: 10550082

Vertical Transmission Rates for HIV in the British Isles: Estimates Based on Surveillance Data

Overview
Journal BMJ
Specialty General Medicine
Date 1999 Nov 5
PMID 10550082
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To estimate and interpret time trends in vertical transmission rates for HIV using data from national obstetric and paediatric surveillance registers.

Design: Prospective study of HIV infected women reported through obstetric surveillance. HIV infection status of the child and onset of AIDS were reported through paediatric surveillance. Rates of vertical transmission and progression to AIDS rate were estimated by methods that take account of incomplete follow up of children with indeterminate infection status and delay in AIDS reporting.

Setting: British Isles.

Subjects: Pregnant women infected with HIV whose infection was diagnosed before delivery, and their babies.

Main Outcome Measures: Mother to child transmission of infection and progression to AIDS in children.

Results: By January 1999, 800 children born to diagnosed HIV infected women who had not breast fed had been reported. Vertical transmission rates rose to 19.6% (95% confidence interval 8. 0% to 32.5%) in 1993 before falling to 2.2% (0% to 7.8%) in 1998. Between 1995 and 1998 use of antiretroviral treatment increased significantly each year, reaching 97% of live births in 1998. The rate of elective caesarean section remained constant, at around 40%, up to 1997 but increased to 62% in 1998. Caesarean section and antiretroviral treatment together were estimated to reduce risk of transmission from 31.6% (13.6% to 52.2%) to 4.2% (0.8% to 8.5%). The proportion of infected children developing AIDS in the first 6 months fell from 17.7% (6.8% to 30.8%) before 1994 to 7.2% (0% to 15. 7%) after, coinciding with increased use of prophylaxis against Pneumocystis carinii pneumonia.

Conclusions: In the British Isles both HIV related morbidity and vertical transmission are being reduced through increased use of interventions.

Citing Articles

Induced abortions of women living with HIV in Finland 1987-2019: a national register study.

Mutru M, Kivela P, Ollgren J, Liitsola K, Gissler M, Aho I BMC Pregnancy Childbirth. 2023; 23(1):120.

PMID: 36800943 PMC: 9938577. DOI: 10.1186/s12884-023-05430-x.


Trends in management and outcomes of pregnant women living with HIV between 2008-2013 and 2014-2019: A retrospective cohort study.

Brandon O, Chakravarti S, Hemelaar J Front Med (Lausanne). 2022; 9:970175.

PMID: 36341266 PMC: 9632995. DOI: 10.3389/fmed.2022.970175.


Overall Vertical Transmission of Hepatitis C Virus, Transmission Net of Clearance, and Timing of Transmission.

Ades A, Gordon F, Scott K, Collins I, Claire T, Pembrey L Clin Infect Dis. 2022; 76(5):905-912.

PMID: 35403676 PMC: 9989130. DOI: 10.1093/cid/ciac270.


An observational study of initial HIV RNA decay following initiation of combination antiretroviral treatment during pregnancy.

Alagaratnam J, Peters H, Francis K, Kay N, Gilleece Y, Finnerty F AIDS Res Ther. 2020; 17(1):41.

PMID: 32660502 PMC: 7359473. DOI: 10.1186/s12981-020-00297-w.


Factors Associated with Maternal-Child Transmission of HIV-1 in Southeastern Brazil: A Retrospective Study.

do Prado T, Brickley D, Hills N, Zandonade E, Moreira-Silva S, Miranda A AIDS Behav. 2018; 22(Suppl 1):92-98.

PMID: 29845389 PMC: 6045966. DOI: 10.1007/s10461-018-2172-8.


References
1.
Nicoll A, McGarrigle C, Brady A, Ades A, Tookey P, Duong T . Epidemiology and detection of HIV-1 among pregnant women in the United Kingdom: results from national surveillance 1988-96. BMJ. 1998; 316(7127):253-8. PMC: 2665507. DOI: 10.1136/bmj.316.7127.253. View

2.
Mandelbrot L, Le Chenadec J, Berrebi A, Bongain A, Benifla J, Delfraissy J . Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort. JAMA. 1998; 280(1):55-60. DOI: 10.1001/jama.280.1.55. View

3.
Lorenzi P, Spicher V, Laubereau B, Hirschel B, Kind C, Rudin C . Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study. AIDS. 1999; 12(18):F241-7. DOI: 10.1097/00002030-199818000-00002. View

4.
Kind C, Rudin C, Siegrist C, Wyler C, Biedermann K, Lauper U . Prevention of vertical HIV transmission: additive protective effect of elective Cesarean section and zidovudine prophylaxis. Swiss Neonatal HIV Study Group. AIDS. 1998; 12(2):205-10. DOI: 10.1097/00002030-199802000-00011. View

5.
. Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. Lancet. 1999; 353(9158):1035-9. DOI: 10.1016/s0140-6736(98)08084-2. View